Daniel Neureiter

30PUBLICATIONS
73CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersEducation assessment and evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 13, 2026
The evolution of cancer therapeutics: from "undruggable" to "drugged".

|Apr 15, 2026
Challenges and innovations in adjuvant therapy for gallbladder cancer: a meta-analytic perspective.

Daniel Neureiter, Matthias Ocker

|Mar 27, 2026
Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma.

Daniel Neureiter, Tobias Kiesslich, Matthias Ocker

|Mar 14, 2026
The Role of Prognostic Clinical-Pathological, (Immuno-) Histological, and Molecular Parameters in Pseudomyxoma Peritonei Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis.

Jan Philipp Ramspott, Anna Kolmhofer, Lukas Schabl-Cayron

|Jan 28, 2026
Clinical Endoscopic Submucosal Dissection of Trainees Tutored by Experts-ESGE Endorsed Courses and Live Endoscopic Events 2011-2015.

Daniel Neureiter, Naohisa Yahagi, Tsuneo Oyama

|Jan 25, 2025
Does Total Neoadjuvant Therapy Impact Surgical Precision in Total Mesorectal Excision? A Nationwide Survey of the Experiences of Expert Surgeons.

Tarkan Jäger, Matthias Zitt, Stefan Riss

Pageof 5

Frequent Collaborators

9 joint publications

Matthias Ocker

5 joint publications

Tarkan Jäger

5 joint publications

Tobias Kiesslich

4 joint publications

Dino Bekric